Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1621-1632

  Palframan, Roger T ^a   Collins, Paul D ^a   Severs, Nicholas J ^b   Rothery, Stephen ^b   Williams, Timothy J ^a   Rankin, Sara M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Bone marrow; Eosinophil; Integrin; Interleukin 5; Phosphatidylinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INTEGRIN; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; RAPAMYCIN; RECOMBINANT INTERLEUKIN 5; WORTMANNIN;

ALLERGY; ANIMAL CELL; ARTICLE; BONE MARROW; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHIL; GUINEA PIG; IMMUNE RESPONSE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD18; BONE MARROW; CELL ADHESION MOLECULES; CELL MOVEMENT; CHROMONES; ENZYME INHIBITORS; EOSINOPHILS; GUINEA PIGS; HUMANS; INTEGRIN ALPHA4; INTERLEUKIN-5; MALE; MICROSCOPY, ELECTRON; MORPHOLINES; RECOMBINANT PROTEINS; SIROLIMUS;

EID: 0032476608     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1621     Document Type: Article

References (57)

1. Clutterbuck, E.J., E.M. Hirst, and C.J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood. 73: 1504-1512.
2. Sanderson, C.J., D.G. Warren, and M. Strath. 1985. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J. Exp. Med. 162:60-74.
3. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43-56.
4. Dent, L.A., M. Strath, A.L. Mellor, and C.J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172:1425-1431.
5. Takafuji, S., K. Tadokoro, and K. Ito. 1996. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. Allergy. 51:563-568.
6. Warringa, R.A.J., H.J.J. Mengelers, P.H.M. Kuijper, J.A.M. Raaijmakers, P.L.B. Bruijnzeel, and L. Koenderman. 1992. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood. 79: 1836-1841.
7. Warringa, R.A.J., R.C. Schweizer, T. Maikoe, P.H.M. Kuijper, P.L.B. Bruijnzeel, and L. Koenderman. 1992. Modulation of eosinophil chemotaxis by interleukin-5. Am. J. Respir. Cell Mol. Biol. 7:631-636.
8. Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. 1991. Analysis of the survival of mature human eosinophils: IL-5 prevents apoptosis in mature human eosinophils. Blood. 78:2542-2547.
9. Hamid, Q., S. Majumder, M. Shepphard, B. Corrin, C.M. Black, R.M. du Bois, and T.K. Jeffery. 1993. Expression of IL-4, IL-5, IFNγ and IL-2 mRNA in fibrosing alveolitis associated with systemic sclerosis. Am. Rev. Respir. Dis. 147: A479.(Abstr.)
10. Bachert, C., M. Wagenmann, U. Hauser, and C. Rudack. 1997. IL-5 synthesis is upregulated in human nasal polyp tissue. J. Allergy Clin. Immunol. 99:837-842.
11. Kay, A.B., S. Ying, V. Varney, M. Gaga, S.R. Durham, R. Moqbel, A.J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:775-778.
12. Durham, S.R., S. Ying, V.A. Varney, M.R. Jacobson, R.M. Sudderick, I.S. Mackay, A.B. Kay, and Q.A. Hamid. 1992. Cytokine messenger RNA expression for IL-1, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:2390-2394.
13. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703-708.
14. Desreumaux, P., A. Janin, S. Dubucquoi, M. Copin, G. Torpier, A. Capron, M. Capron, and L. Prin. 1993. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood. 82:1553-1560.
15. Yamaguchi, S., H. Nagai, H. Tanaka, M. Tsujimoto, and N. Tsuruoka. 1994. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci. 54:471-475.
16. Corrigan, C.J., A. Haczku, V. Gemou-Engesaeth, S. Doi, Y. Kikuchi, K. Takatsu, S.R. Durham, and A.B. Kay. 1993. CD4 T-lymphocytes activation in asthma is accompanied by increased serum concentrations of interleukin-5. Am. Rev. Respir. Dis. 147:540-547.
17. Kung, T.T., D.M. Stelts, J.A. Zurcher, G.K. Adams III, R.W. Egan, W. Kreutner, A.S. Watnick, H. Jones, and R.W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell. Mol. Biol. 13:360-365.
18. Mauser, P.J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A.S. Watnick, R.W. Egan, W. Kreutner, and K.G. Adams. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623-1627.
19. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
20. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, and A. Mantovani. 1989. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701-705.
21. Griffiths-Johnson, D.A., P.D. Collins, A.G. Rossi, P.J. Jose, and T.J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro, and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197: 1167-1172.
22. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
23. Jose, P.J., I.M. Adcock, D.A. Griffiths-Johnson, N. Berkman, T.N.C. Wells, T.J. Williams, and C.A. Power. 1994. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem. Biophys. Res. Commun. 205:788-794.
24. Humbles, A.A., D.M. Conroy, S. Marleau, S.M. Rankin, R.T. Palframan, A.E.I. Proudfoot, T.N.C. Wells, D. Li, P.K. Jeffery, D.A. Griffiths-Johnson, et al. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601-612.
25. Collins, P.D., S. Marleau, D.A. Griffiths-Johnson, P.J. Jose, and T.J. Williams. 1995. Co-operation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
26. Mould, A.W., K.I. Matthaei, I.G. Young, and P.S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
27. Kimura, I., Y. Moritani, and Y. Tanizaki. 1973. Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy. 3:195-202.
28. Palframan, R.T., P.D. Collins, T.J. Williams, and S.M. Rankin. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood. 91:2240-2248.
29. Teixeira, M.M., and P.G. Hellewell. 1997. The effect of the selectin binding polysaccharide fucoidin on eosinophil recruitment in vivo. Br J. Pharmacol. 120:1059-1066.
30. Weg, V.B., T.J. Williams, R.R. Lobb, and S. Nourshargh. 1993. A monoclonal antibody recognizing very late activation antigen-4 (VLA-4) inhibits eosinophil accumulation in vivo. J. Exp. Med. 177:561-566.
31. Weg, V.B. and T.J. Williams. 1994. Chemical mediators and adhesion molecules involved in eosinophil accumulation in vivo. Ann. NY Acad. Sci. 725:146-155.
32. Schweitzer, K.M., A.M. Drager, P. van der Valk, S.F. Thijsen, A. Zevenbergen, A.P. Theijsmeijer, C.E. van der Schoot, and M.M. Langenhuijsen. 1996. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am. J. Pathol. 148: 165-175.
33. Kapeller, R., and L.C. Cantley. 1994. Phosphatidylinositol 3-kinase. Bioessays. 16:565-576.
34. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269: 3563-3567.
35. Vlahos, C.J., W.F. Matter, K.Y. Hui, and R.F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
36. Becker, R.P., and P.P. De Bruyn. 1976. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am. J. Anat. 145:183-205.
37. De Bruyn, P.P., S. Michelson, and T.B. Thomas. 1971. The migration of blood cells of the bone marrow through the sinusoidal wall. J. Morphol. 133:417-437.
38. De Bruyn, P.P. 1983. Transcellular cell movement and the formation of metastases. Perspect. Biol. Med. 26:441-450.
39. Feng, D., J.A. Nagy, K. Pyne, H.F. Dvorak, and A.M. Dvorak. 1998. Neutrophils emigrate from venules by a transendothelial cell pathway in response to fmlp. J. Exp. Med. 187:903-915.
40. Cook, R.M., H. Smith, and B.A. Spicer. 1993. Animal models of eosinophils. In Immunopharmacology of Eosinophils. H. Smith and R.M. Cook, editors. Academic Press, London. 193-216.
41. van Eeden, S.F., R. Miyagashima, L. Haley, and J.C. Hogg. 1997. A possible role for L-selectin in the release of polymorphonuclear leukocytes from bone marrow. Am. J. Physiol. 272:H1717-1724.
42. Walsh, G.M., A. Hartnell, A.J. Wardlaw, K. Kurihara, C.J. Sanderson, and A.B. Kay. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology. 71: 258-265.
43. Das, A.M., T.J. Williams, R.R. Lobb, and S. Nourshargh. 1995. Lung eosinophilia is dependent on IL-5, and the adhesion molecules CD18 and VLA-4 in a guinea-pig model. Immunology. 84:41-46.
44. Nakajima, H., H. Sano, T. Nishimura, S. Yoshida, and I. Iwamoto. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1145-1154.
45. Schweizer, R.C., B.A.C. van Kessel-Welmers, R.A.J. Warringa, T. Maikoe, J.A.M. Raaijmakers, J.J. Lammers, and L. Koenderman. 1996. Mechanisms involved in eosinophil migration. Platelet-activating factor-induced chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals. J. Leukocyte Biol. 59:347-356.
46. De Bruyn, P.P., P.C. Breen, and T.B. Thomas. 1970. The microcirculation of the bone marrow. Anat. Rec. 168:55-68.
47. Pazdrak, K., S. Stafford, and R. Alam. 1995. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J. Immunol. 155:397-402.
48. Pazdrak, K., D. Schreiber, P. Forsythe, L. Justement, and R. Alam. 1995. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J. Exp. Med. 181:1827-1834.
49. Coffer, P.J., R.C. Schweizer, G.R. Dubois, T. Maikoe, J.J. Lammers, and L. Koenderman. 1998. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood. 91:2547-2557.
50. Wennstrom, S., A. Siegbahn, K. Yokote, A.K. Arvidsson, C.H. Heldin, S. Mori, and L. Claesson Welsh. 1994. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene. 9:651-660.
51. Wennstrom, S., P. Hawkins, F. Cooke, K. Hara, K. Yonezawa, M. Kasuga, T. Jackson, L. Claesson Welsh, and L. Stephens. 1994. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4:385-393.
52. Turner, L., S.G. Ward, and J. Westwick. 1995. RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase. J. Immunol. 155:2437-2444.
53. Franke, T.F., S.I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, and P.N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727-736.
54. Burgering, B.M., and P.J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:599-602.
55. Rankin, S., R. Hooshmand Rad, L. Claesson Welsh, and E. Rozengurt. 1996. Requirement for phosphatidylinositol 3′-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p 125 focal adhesion kinase and paxiffin. J. Biol. Chem. 271:7829-7834.
56. Chung, J., T.C. Grammer, K.P. Lemon, A. Kazlauskas, and J. Blenis. 1994. PDGF-and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature. 370:71-75.
57. Hom, J.T., and T. Estridge. 1993. FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils. Clin. Immunol. Immunopathol. 68:293-300.